Facts You Need to Understand POINT Biopharma Global Stock

By Blake Campbell • Monday, December 18 12:26 • Permanent Link

Small-cap Health Care company POINT Biopharma Global has moved -11.2% so far today on a volume of 9,721,082, compared to its average of 2,983,282. In contrast, the S&P 500 index moved 1.0%.

POINT Biopharma Global trades -14.52% away from its average analyst target price of $14.57 per share. The 7 analysts following the stock have set target prices ranging from $12.5 to $27.0, and on average have given POINT Biopharma Global a rating of hold.

Anyone interested in buying PNT should be aware of the facts below:

POINT Biopharma Global has moved 116.0% over the last year, and the S&P 500 logged a change of 23.6%
Based on its trailing earnings per share of 1.1, POINT Biopharma Global has a trailing 12 month Price to Earnings (P/E) ratio of 11.3 while the S&P 500 average is 15.97
PNT has a forward P/E ratio of -12.1 based on its forward 12 month price to earnings (EPS) of $-1.03 per share
Its Price to Book (P/B) ratio is 3.11 compared to its sector average of 4.08
POINT Biopharma Global Inc., a radiopharmaceutical company, develops and commercializes radioligands that fight cancer.
Based in Indianapolis, the company has 129 full time employees and a market cap of $1.33 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.